TAG:
pathology services
“Value Added†Services Essential to Success
By R. Lewis Dark | From the Volume VI No. 2 – February 1, 1999 Issue
ONE ELEMENT COMMON TO SUCCESSFUL LABORATORY ORGANIZATIONS of the future will be the ability to both understand the concept of “value added†services and to offer such services to customers. At its core, value added is an essential business strategy. There are many ways to define “value added.â…
IMPATH Creates Its Brand Of Value-Added Pathology
By Robert Michel | From the Volume VI No. 2 – February 1, 1999 Issue
CEO SUMMARY: IMPATH Inc. is a pathology company with an interesting twist. It doesn’t compete directly with community hospital-based pathologists like some national AP providers. Instead, it offers AP services which supplement the capabilities of the local pathologist. The formula must …
IMPATH Points Pathology Toward a Winning Future
By Robert Michel | From the Volume VI No. 2 – February 1, 1999 Issue
CEO SUMMARY: Pathology is about to undergo a market transformation similar to radiology. As clinicians insist on more precise diagnostic and prognostic information about their patients, pathologists will have a perfect opportunity to reposition themselves as essential partners with the re…
Top-Performing Labs at Executive War College
By Robert Michel | From the Volume VI No. 2 – February 1, 1999 Issue
CEO SUMMARY: Once again, Executive War College time approaches. Scheduled for May 11-12, 1999 at the New Orleans Sheraton, this year’s roster of innovative laboratories promises to provide valuable insight about winning strategies. An expanded program offers a lab industry first: a know…
DIANON Wins Contract, Buys Kyto Meridien Lab
By Robert Michel | From the Volume VI No. 1 – January 11, 1999 Issue
CEO SUMMARY:Anatomic pathology took another forward step on the managed care battleground. DIANON Systems, Inc. gained status as a provider of anatomic pathology services under the new master agreement announced by Oxford Health Plans. DIANON’s success demonstrates that anatomic patholo…
PPM Giant MedPartners Exits Doctor Management
By Robert Michel | From the Volume V No. 16 – November 30, 1998 Issue
THIRD IN A SERIES WHAT DOES IT MEAN WHEN the largest companies in a multibillion dollar industry announce that they will “get out†of that business? That is the question which must be answered after MedPartners, Inc. joined PhyMatrix Corp. in p…
PathSOURCE Is Newest Pathology Consolidator
By Robert Michel | From the Volume V No. 15 – November 9, 1998 Issue
CEO SUMMARY: Based in New York, PathSOURCE becomes the newest pathology network and services company to hit the market. PathSOURCE’s organizers want to link “best in class†dermatopathologists and academic pathology subspecialists to compete for outreach pathology specimens. PathSOU…
Pathology PPMs Unlike Most Other PPM Firms
By Robert Michel | From the Volume V No. 14 – October 19, 1998 Issue
PHYSICIAN PRACTICE MANAGEMENT (PPM) companies have arrived at pathology’s doorstep. For better or worse, a new era is pushing its way into the pathology profession. In the first installment of this exclusive DARK REPORT series, we exposed the rotten secret behind the …
Pathologists Will Learn Income-Boosting Methods
By Robert Michel | From the Volume V No. 13 – September 28, 1998 Issue
CEO SUMMARY: Reimbursement for pathology services continues to decline. Despite this fact, savvy pathologists throughout the country are steadily increasing their take-home income. Their proven methods and secret strategies will be the theme of the Private Pathology Income Symposium. This…
DIANON Shoots At Urocor, Makes Unwelcome Offer
By Robert Michel | From the Volume V No. 12 – September 8, 1998 Issue
CEO SUMMARY: It pays to know your friends. Last month DIANON Systems announced an unsolicited offer to acquire UroCor. The offer, following months of ongoing discussions between the two companies, was clearly unwelcome at UroCor. Both companies are pushing hard to evolve disease managemen…
CURRENT ISSUE

Volume XXXII, No. 10 – July 14, 2025
This issue is strong on different flavors of enforcement that clinical laboratories, whether they want to or not, will need to contend with. Lab stakeholders provide insights that medical labs need to brace for more action to counter pending test reimbursement rate cuts under PAMA. Also, this issue provides the legal and regulatory landscape for clinical labs’ use of AI and how it evolves with the technology. AI is creating legal uncertainty for clinical labs, especially around data privacy and FDA oversight of AI tools in diagnostics.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized